The pH-triggered polyglutamate brush co-delivery of MDR1 and survivin-targeting siRNAs efficiently overcomes multi-drug resistance of NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The pH-triggered polyglutamate brush co-delivery of MDR1 and survivin-targeting siRNAs efficiently overcomes multi-drug resistance of NSCLC

Published:2020-09-21 Issue:11 Volume:46 Page:1862-1872
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Wang Zhongjuan¹,Liang Yueqin¹,Liu Yanqiu¹,Xia Hongying¹,Liu Jianqi¹,Jin Xingfang¹,Li Zhongkun¹

Affiliation:

1. Department of Pharmacy, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, PR China

Funder

Joint Fund for Kunming Medical University and Yunnan Applied Basic Research

Open Foundation of the Key Laboratory of Tumor Immunotherapy in Yunnan Province

Kunming Science and Technology Plan Project

Hospital Project of Yan'an Hospital Affiliated to Kunming Medical University

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2020.1822860

Reference27 articles.

1. Cancer statistics, 2019

2. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis

3. Targeting Epidermal Growth Factor Receptor in Non-Small-Cell-Lung Cancer: Current State and Future Perspective

4. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020

5. Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan-based smart stimuli-responsive nanoparticles for gene delivery and gene therapy: Recent progresses on cancer therapy;International Journal of Biological Macromolecules;2024-10

2. Non-viral vectors combined delivery of siRNA and anti-cancer drugs to reverse tumor multidrug resistance;Biomedicine & Pharmacotherapy;2024-09

3. Smart Physicochemical-triggered Chitosan-based Nanogels for siRNA Delivery and Gene Therapy: A Focus on Emerging Strategies and Paradigms for Cancer Therapy;Current Medicinal Chemistry;2024-06-05

4. Targeting Rab26 to Conquer Cisplatin-Resistant Lung Cancer with Self-Assembled DNA Nanomaterials;Biomacromolecules;2023-04-03

5. Precision targeted therapy for EGFR mutation‐positive NSCLC: Dilemmas and coping strategies;Thoracic Cancer;2023-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3